PTC Therapeutics taps experimental cancer drug for new COVID-19 trial

PTC Therapeutics is throwing its hat in the ring for a potential reworked pipeline med against COVID-19.

The biopharma, which has been focused on rare diseases, is tapping its early-stage cancer drug, currently in a test for certain leukemias, to see whether it can help patients afflicted with the disease.